Esperion announces Otsuka submitted NDA to Japanese MHLW for bempedoic acid
Esperion (ESPR) announced that Otsuka Pharmaceutical (OSUKF) has submitted a New Drug Application, NDA, to the Japanese Ministry of Health, ...